Health Trials

About this trial

The Bialystok Bariatric Surgery Study (BBSS) is a prospective observational cohort study of patients undergoing bariatric surgery at the First Clinical Department of General and Endocrine Surgery at the Medical University of Bialystok. The BBSS consists of a battery of baseline tests established one month prior to the surgery and repeated at one, three, six, twelve and twenty four-month follow-up clinical visits.

Eligibility criteria

Qualifiers

BMI ≥ 40 kg/m2, or BMI ≥ 35 and at least one or more obesity-related co-morbidities such as type 2 diabetes (T2D), hypertension, sleep apnea and other respiratory disorders, non-alcoholic fatty liver disease, osteoarthritis, lipid abnormalities, gastrointestinal disorders, or heart disease.

Inability to achieve a healthy weight loss sustained for a period of time with prior weight loss efforts

Patient consent for participation in research project

Willingness in participation in follow-up visits

Disqualifiers

substance abuse,

uncontrolled psychiatric illness

expected lack of compliance

advanced-stage cancer

Trial design

Treatments tested in this trial

  • Bariatric surgery

Treatment groups

1,000 Participants
are divided into 3 treatment groups

Locations

1
Clinical Research Centre, Medical University of Bialystok15-276, BialystokPodlaskie Voivodeship, Poland

Sponsors and collaborators

Medical University of Bialystok

Lead sponsor

University of Copenhagen

Collaborator

Source ClinicalTrials.gov